Clinical and Experimental Medicine

Papers
(The median citation count of Clinical and Experimental Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Sjögren’s syndrome: a systemic autoimmune disease157
Anemia in patients with Covid-19: pathogenesis and clinical significance78
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options69
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis48
Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta-analysis46
Kidney disease and COVID-19 disease severity—systematic review and meta-analysis44
A review of prognostic and predictive biomarkers in breast cancer36
Zinc as a complementary treatment for cancer patients: a systematic review34
COVID-19: time to flatten the infodemic curve25
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart23
The use of ketogenic diets in cancer patients: a systematic review22
Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer20
A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis18
Stem cells therapy in acute myocardial infarction: a new era?18
Immune-inflammatory, coagulation, adhesion, and imaging biomarkers combined in machine learning models improve the prediction of death 1 year after ischemic stroke18
The NEK family of serine/threonine kinases as a biomarker for cancer17
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance12
Increased TIM-3+PD-1+ NK cells are associated with the disease activity and severity of systemic lupus erythematosus12
Vascular endothelial growth factors and angiopoietins as new players in mastocytosis12
REC8 promotes tumor migration, invasion and angiogenesis by targeting the PKA pathway in hepatocellular carcinoma11
The role of mast cells in human skin cancers10
Tumor-resident adenosine-producing mesenchymal stem cells as a potential target for cancer treatment10
The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity10
Exosomes derived from mesenchymal stem cells regulate Treg/Th17 balance in aplastic anemia by transferring miR-23a-3p10
The association between serum liver enzymes and cancer mortality9
Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness9
Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity9
Overexpression of miR-1225 promotes the progression of breast cancer, resulting in poor prognosis9
Do pentraxin 3 and neural pentraxin 2 have different facet function in hepatocellular carcinoma?7
Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis7
Altered peripheral helper T cells in peripheral blood and muscle tissue of the patients with dermatomyositis7
Meta-analysis of the benefit of hypomethylating agents before allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes7
Mesangial IgM deposition predicts renal outcome in patients with IgA nephropathy: a multicenter, observational study7
Pancreatic MR imaging and endocrine complications in patients with beta-thalassemia: a single-center experience7
Usefulness of rapid antigen testing for SARS-CoV-2 screening of healthcare workers: a pilot study6
miR-1253, a novel tumor suppressor gene in colon cancer, is associated with poor patients prognosis6
Lymphoma subtypes in India: a tertiary care center review6
Different spatial distribution of inflammatory cells in the tumor microenvironment of ABC and GBC subgroups of diffuse large B cell lymphoma6
Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study6
Expression profile of PU.1 in CD4+T cells from patients with systemic lupus erythematosus5
TGFB1 (rs1800470 and rs1800469) variants are independently associated with disease activity and autoantibodies in rheumatoid arthritis patients5
Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma5
IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma5
The risk factors for early mortality and end-stage renal disease in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: experiences from a single center5
Impact of cathepsin D activity and C224T polymorphism (rs17571) on chronic obstructive pulmonary disease: correlations with oxidative and inflammatory markers5
0.021307945251465